Wednesday Lecture Series: “Changing the Paradigm for Treatment Resistant Depression: Neurostimulation Update”
This activity is intended for physicians, nurses, psychologists, social workers, counselors and other mental health professionals.
1. Define treatment resistant depression (TRD).
2. Describe the proposed mechanism of action for transcranial magnetic stimulation (TMS).
3. Identify patients who are candidates for vagus nerve stimulation (VNS).
Scott T. Aaronson, MD, is Director of Clinical Research Programs at Sheppard Pratt Health System in Baltimore, Maryland. He has particularly been involved with the development of new strategies to alleviate the symptoms in treatment resistant mood disorders. Dr. Aaronson earned his medical degree with honors from Harvard Medical School in Boston and completed a residency in Psychiatry at McLean Hospital in Belmont, Massachusetts. He is a Clinical Associate Professor of Psychiatry at the University of Maryland, School of Medicine.
He is a valued member of the Sheppard Pratt community where he provides expert consultation across the system of care for patients with difficult to treat mood and psychotic disorders.
He has published numerous articles on his research including pivotal studies in the use of devices—Transcranial Magnetic Stimulation (TMS) and Vagus Nerve Stimulation (VNS) in the treatment of severe refractory mood disorders.
Dr. Aaronson is board-certified in Psychiatry and he is a member of several professional organizations, including Distinguished Fellowship in the American Psychiatric Association and the Maryland Psychiatric Society for which he served as President. He is also a fellow of the American College of Psychiatrists and an elected board member of the Clinical TMS Society and the American Society for Clinical Psychopharmacology.
Physician Statement: Sheppard Pratt Health System is accredited by The Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. Sheppard Pratt Health System designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Statement: Sheppard Pratt Health System is an approved provider of continuing nursing education by Maryland Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. This activity is approved for 1.0 contact hours for nurses.
Psychologist Statement: Sheppard Pratt Health System is authorized by the State Board of Examiners of Psychologists as a sponsor of continuing education. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. Sheppard Pratt Health System designates this educational activity for a maximum of 1.0 CEU hours for Psychologists. Psychologists should claim credit commensurate with the extent of their participation in the activity.
Social Worker Statement: Sheppard Pratt Health System is authorized by the Board of Social Work Examiners of Maryland to offer continuing education for Social Workers. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. This activity is approved for 1.0 CEU contact hours in Category 1 credits for Social Workers.
Counselor Statement: Sheppard Pratt Health System has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5098. Programs that do not qualify for NBCC credit are clearly identified. Sheppard Pratt Health System is solely responsible for all aspects of the program. This activity is available for 1.0 NBCC clock hours.
- 1.00 ACEP NBCC clock hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Category I credits for Social Workers
- 1.00 Psychologists
- 1.00 Participation